A practical approach to pediatric patients referred with an abnormal coagulation profile

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 8, 2005, Pages 1011-1016

  Acosta, Monica ^a   Edwards, Rachel ^a   Ian Jaffe, E ^a   Yee, Donald L ^a   Mahoney, Donald H ^a   Teruya, Jun ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD CLOTTING; CHILD; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT REFERRAL; PEDIATRICS; PREDICTION; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDIZATION;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CHILD; FEMALE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; PEDIATRICS; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 23044472133     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lusher JM. Screening and diagnosis of coagulation disorders. Am J Obstet Gynecol. 1996;175:778-783.
2. Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem. 1997;43:1348-1351.
3. Rao LV, Okorodudu AO, Petersen JR, et al. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clin Chim Acta. 2000;300:13-21.
4. Clinical and Laboratory Standards Institute (formerly NCCLS). Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays. 3rd ed. Wayne, Pa: NCCLS; 1998. Approved guideline H21-A2.
5. Mahoney DH, Steuber CP, Hurwitz R, et al. Impact of managed care practices on the evaluation of children with suspected bleeding disorders. J Pediatr Hematol Oncol. 1999;21:325.
6. Patel RI, DeWitt L, Hannallah RS. Preoperative laboratory testing in children undergoing elective surgery: analysis of current practice. J Clin Anesth. 1997;9: 569-575.
7. Sandoval C, Dong S, Visintainer P, et al. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol. 2002;24:47-49.
8. Dilley A, Drews C, Miller C, et al. Von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol. 2001;97:663-666.
9. Chambost H, Gaboulaund V, Coatmelec B, et al. What factors influence the age of diagnosis of hemophilia? Results of the French hemophilia cohort. J Pediatr. 2002;141:548-552.
10. Krashinki SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985;41:639-643.
11. Pottinger BE, Read RC, Paleolog EM, et al. Von Willebrand factor is an acute phase reactant in man. Thromb Res. 1989;53:387-395.
12. Nichols WC, Ginsburg D. von Willebrand disease. Medicine. 1997;76:1-20.
13. Sham RL, Francis CW. Evaluation of mild bleeding disorders and easy bruising. Blood Rev. 1994;8:98-104.
14. Teruya J, Oropeza M, Ramsey G. A normal aPTT does not guarantee adequate coagulation factor levels. Anesthesiology. 2001;94:542.
15. Wojtkowski TA, Rutledge JC, Matthews DC. The clinical impact of increased sensitivity PT and APTT coagulation assays. Am J Clin Pathol. 1999;112: 225-232.
16. Male C, Lechner K, Eichinger S, et al. Clinical significance of lupus anticoagulants in children. J Pediatr. 1999;134:199-205.
17. Shi W, Krilis SA, Chong BH, et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med. 1990;20:231-236.
18. Taylor LJ. Laboratory management of the bleeding patient. Clin Lab Sci. 2003;16:111-114.